[HTML][HTML] Antiretroviral therapy for prevention of tuberculosis in adults with HIV: a systematic review and meta-analysis
Background Human immunodeficiency virus (HIV) infection is the strongest risk factor for
developing tuberculosis and has fuelled its resurgence, especially in sub-Saharan Africa. In …
developing tuberculosis and has fuelled its resurgence, especially in sub-Saharan Africa. In …
Global and regional molecular epidemiology of HIV-1, 1990–2015: a systematic review, global survey, and trend analysis
J Hemelaar, R Elangovan, J Yun… - The Lancet infectious …, 2019 - thelancet.com
Background Global genetic diversity of HIV-1 is a major challenge to the development of HIV
vaccines. We aimed to estimate the regional and global distribution of HIV-1 subtypes and …
vaccines. We aimed to estimate the regional and global distribution of HIV-1 subtypes and …
The contribution of a gender perspective to the understanding of migrants' health
A Llácer, MV Zunzunegui, J Del Amo… - … of Epidemiology & …, 2007 - jech.bmj.com
In 2005 women represented approximately half of all 190 million international migrants
worldwide. This paper addresses the need to integrate a gender perspective into …
worldwide. This paper addresses the need to integrate a gender perspective into …
Sociodemographic and psychological variables influencing adherence to antiretroviral therapy
V Gordillo, J del Amo, V Soriano, J González-Lahoz - Aids, 1999 - journals.lww.com
Objective: To assess the degree of compliance with antiretroviral therapy in HIV-infected
patients, and identify which sociodemographic and psychological factors influence it, in …
patients, and identify which sociodemographic and psychological factors influence it, in …
Incidence and severity of COVID-19 in HIV-positive persons receiving antiretroviral therapy: a cohort study
Background: The incidence and severity of coronavirus disease 2019 (COVID-19) among
HIV-positive persons receiving antiretroviral therapy (ART) have not been characterized in …
HIV-positive persons receiving antiretroviral therapy (ART) have not been characterized in …
Long-term mortality in HIV-positive individuals virally suppressed for> 3 years with incomplete CD4 recovery
FN Engsig, R Zangerle, O Katsarou… - Clinical infectious …, 2014 - academic.oup.com
Background. Some human immunodeficiency virus (HIV)–infected individuals initiating
combination antiretroviral therapy (cART) with low CD4 counts achieve viral suppression but …
combination antiretroviral therapy (cART) with low CD4 counts achieve viral suppression but …
HIV testing and counselling for migrant populations living in high-income countries: a systematic review
D Alvarez-del Arco, S Monge, A Azcoaga… - … European Journal of …, 2013 - academic.oup.com
Background: The barriers to HIV testing and counselling that migrants encounter can
jeopardize proactive HIV testing that relies on the fact that HIV testing must be linked to care …
jeopardize proactive HIV testing that relies on the fact that HIV testing must be linked to care …
Time From Human Immunodeficiency Virus Seroconversion to Reaching CD4+ Cell Count Thresholds <200, <350, and <500 Cells/mm3: Assessment of Need …
Background. Recent updates of human immunodeficiency virus (HIV) treatment guidelines
have raised the CD4+ cell count thresholds for antiretroviral therapy initiation from 350 to …
have raised the CD4+ cell count thresholds for antiretroviral therapy initiation from 350 to …
[HTML][HTML] Consensus statement on the role of health systems in advancing the long-term well-being of people living with HIV
JV Lazarus, K Safreed-Harmon… - Nature …, 2021 - nature.com
Health systems have improved their abilities to identify, diagnose, treat and, increasingly,
achieve viral suppression among people living with HIV (PLHIV). Despite these advances, a …
achieve viral suppression among people living with HIV (PLHIV). Despite these advances, a …
Impact of HIV-1 subtype on CD4 count at HIV seroconversion, rate of decline, and viral load set point in European seroconverter cohorts
Background. Human immunodeficiency virus type 1 (HIV-1) subtype may influence disease
progression. We compared CD4 lymphocyte cell count levels at seroconversion, decline …
progression. We compared CD4 lymphocyte cell count levels at seroconversion, decline …